BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28223721)

  • 1. Current and future therapies for inherited cholestatic liver diseases.
    van der Woerd WL; Houwen RH; van de Graaf SF
    World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
    van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
    Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
    J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
    Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
    Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
    Sticova E; Jirsa M; Pawłowska J
    Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive familial intrahepatic cholestasis.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Orphanet J Rare Dis; 2009 Jan; 4():1. PubMed ID: 19133130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
    Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
    J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive familial intrahepatic cholestasis.
    Srivastava A
    J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial intrahepatic cholestasis: New and wide perspectives.
    Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
    Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease associated with canalicular transport defects: current and future therapies.
    Stapelbroek JM; van Erpecum KJ; Klomp LW; Houwen RH
    J Hepatol; 2010 Feb; 52(2):258-71. PubMed ID: 20034695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive familial intrahepatic cholestasis type 1.
    Paulusma CC; Elferink RP; Jansen PL
    Semin Liver Dis; 2010 May; 30(2):117-24. PubMed ID: 20422494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canalicular ABC transporters and liver disease.
    Nicolaou M; Andress EJ; Zolnerciks JK; Dixon PH; Williamson C; Linton KJ
    J Pathol; 2012 Jan; 226(2):300-15. PubMed ID: 21984474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.
    van Mil SW; van der Woerd WL; van der Brugge G; Sturm E; Jansen PL; Bull LN; van den Berg IE; Berger R; Houwen RH; Klomp LW
    Gastroenterology; 2004 Aug; 127(2):379-84. PubMed ID: 15300568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
    Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
    J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive familial intrahepatic cholestasis. Genetic basis and treatment.
    Jacquemin E
    Clin Liver Dis; 2000 Nov; 4(4):753-63. PubMed ID: 11232355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.